Bharat Parenterals Ltd

Bharat Parenter. | 541096

Market Closed

₹1,410.35

₹0.28 (-0.02%)

As on 10/07/26, 11:42 PM

Market Cap--- CR

Current Price₹---

High / Low₹--- / ---

PE Ratio0

Book Value₹479.79

Dividend Yield0.10%

ROCE-4.76%

ROE8.81%

Face Value₹2.00

Current Vol.---

Average Vol.---

ISININE365Y01019

PB Ratio2.06

Debt to Equity0.64

Net Profit Margin-12.83

Operating Margin4.21

Share Price Chart - Bharat Parenterals Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹1,410.65₹1,448.95

₹1,410.35

Previous CloseToday's Open

₹880.25₹1,667.2

₹1,410.35

52W Low52W High

₹1,448.95Today's Open

₹1,410.65Previous Close

1,130Volume

₹880.2552W Low

₹1,667.252W High

Ratios

No data available

About Company

Bharat Parenterals Limited was incorporated in September, 1992 in Gujarat and promoted by Ramesh Desai and Bharat Desai
The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda
It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics
In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company on 09 July, 2016
Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020
Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective from 28th June, 2022

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSIN/A

SMA 20N/A

SMA 50N/A

SMA 100N/A

SMA 200N/A

SMA 10N/A

MACD_12_26_DaysN/A

EMA10DayN/A

EMA20DayN/A

EMA50DayN/A

MACD_12_26_9_DaysN/A

EMA100DayN/A

EMA200DayN/A

Pivot Points

Volume Analysis

📊

No Information Available

Volume Analysis data is not available at this time.

Growth Rate

Revenue Growth30.30%

ROE-16.55%

EBITDA Margin4.21%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	340.38	261.22	217.98	212.01	204.64
Interest	12.95	4.02	2.19	0.89	0.39
Expenses	337.68	234.14	198.11	184.36	179.77
Financing Profit	14.32	31.76	31.62	35.43	33.55
Financing Margin %	4%	12%	15%	17%	16%
Other Income	11.62	4.68	11.74	7.78	8.67
Depreciation	35.32	9.02	5.88	6.66	6.03
Profit before tax	-33.95	18.72	23.55	27.88	27.12
Tax %	-29%	44%	33%	25%	25%
Net Profit	-43.68	10.51	15.71	20.81	20.32
EPS in Rs	-66.64	24.94	28.40	36.67	35.59

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

26 Sept 2025

AGM

04 Sept 2025

19 Sept 2025

Final Dividend (₹1)

The Board Recommendation of final dividend of Rs. 1.00/- per equity share of Rs. 10/- each (at the rate of 10%) for financial year ended March 31, 2025. Intimation of Book Closure (As per BSE Announcement Dated on 04.09.2025)

12 May 2025

02 Jul 2024

AGM

10 Jun 2024

25 Jun 2024

Final Dividend (₹1)

Recommendation of final dividend of Rs. 1.00/- per equity share of Rs. 10/- each (at the rate of 10%) for financial year ended March 31, 2024. Please note Dividend will be paid within 30 days from the date of Shareholders' approval at the ensuing Annual General Meeting (AGM) of the Company.

22 May 2024

21 May 2024

EGM

29 Apr 2024

30 Sept 2023

AGM

01 Sept 2023

25 Sept 2023

Final Dividend (₹0.75)

In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 20th May, 2023, has considered and approved the Audited Financial Results for the Quarter and year ended 31st March, 2023 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. The Board has also recommended payment of final dividend of Rs. 0.75 (Rupees Seventy-Five Paise Only) per Equity Share of Rs. 10/- each (fully paid-up) for the financial year ended March 31, 2023 and the same shall be payable subject to approval of the Shareholders at the ensuing Annual General Meeting ('AGM') of the Company.

20 May 2023

27 Sept 2022

AGM

29 Aug 2022

30 Sept 2021

AGM

27 Aug 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
1,410	972	0	3	37	1	-12.83%
1,935	4,64,331	37	6	30	0	19.78%
6,836	1,81,466	69	11	59	0	23.41%
4,903	1,65,952	76	20	50	1	11.09%
1,439	1,16,229	31	3	23	0	9.92%
1,151	1,14,763	21	4	17	0	19.86%
2,496	1,14,128	20	5	16	0	14.56%
2,525	1,04,275	52	6	36	0	14.39%
1,246	1,03,959	26	3	17	0	12.34%
1,565	90,875	26	2	17	0	10.98%

Showing 10 of 134 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Bharat Parenterals Ltd?

The current share price of Bharat Parenterals Ltd (Bharat Parenter.) is ₹1410.35. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Bharat Parenterals Ltd?

The Price-to-Earnings (P/E) ratio of Bharat Parenterals Ltd is 1410.35. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Bharat Parenterals Ltd?

Bharat Parenterals Ltd has a 52-week high of ₹1667.20 and a 52-week low of ₹880.25. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Bharat Parenterals Ltd?

Bharat Parenterals Ltd offers a dividend yield of 0.07%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Bharat Parenterals Ltd?

The Earnings Per Share (EPS) of Bharat Parenterals Ltd is ₹-11.88. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Bharat Parenterals Ltd?

Bharat Parenterals Ltd has a Return on Equity (ROE) of 8.81%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video